Cell-free DNA as a promising marker for risk stratification of pulmonary embolism.
- Published in:
- Critical Care, 2013, v. 17, n. 6, p. 464, doi. 10.1186/cc13118
- By:
- Publication type:
- Article
Works matching AU Neto-Neves, Evandro
Results: 9
1
2
Cell-free DNA as a promising marker for risk stratification of pulmonary embolism.
- Published in:
- 2013
- By:
- Publication type:
- Letter
3
Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.
- Published in:
- Journal of Cellular & Molecular Medicine, 2013, v. 17, n. 12, p. 1588, doi. 10.1111/jcmm.12163
- By:
- Publication type:
- Article
4
Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, v. 385, n. 7, p. 685, doi. 10.1007/s00210-012-0748-9
- By:
- Publication type:
- Article
5
Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, v. 385, n. 2, p. 211, doi. 10.1007/s00210-011-0695-x
- By:
- Publication type:
- Article
6
Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2010, v. 382, n. 4, p. 293, doi. 10.1007/s00210-010-0546-1
- By:
- Publication type:
- Article
7
Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis.
- Published in:
- Physiological Reports, 2022, v. 10, n. 1, p. 1, doi. 10.14814/phy2.15156
- By:
- Publication type:
- Article
8
Recombinant Human Matrix Metalloproteinase-2 Impairs Cardiovascular β-Adrenergic Responses.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2013, v. 112, n. 2, p. 103, doi. 10.1111/bcpt.12001
- By:
- Publication type:
- Article
9
Chronic Treatment with Quercetin does not Inhibit Angiotensin-Converting Enzyme In Vivo or In Vitro.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2010, v. 107, n. 4, p. 825, doi. 10.1111/j.1742-7843.2010.00583.x
- By:
- Publication type:
- Article